Founded in December of 2009, Genesys Spine’s mission was to bring a suite of medical implants and instruments with novel characteristics into a mature spinal fusion market. Since that time, Genesys has released four new FDA cleared product lines with several other products in various stages of the design and development cycle. Genesys has also developed several proprietary instruments to aid in the use of its products. All of Genesys’ inaugural products, including our system specific instruments, have garnered very positive feedback from the marketplace. Our implants, with their proprietary features, all remain within existing parameters for today’s current reimbursement codes.